通过导管治疗中枢狭窄症
1Oregon Health and Science University, Portland, OR, USA.
Cardiology clinics
|June 23, 2024
概括
mitra 门狭窄是常见的和不断变化的. 本综述涵盖了对关狭窄的透导管疗法,针对不同人群中的类风湿和退行性原因.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 膜心脏疾病 膜心脏疾病
背景情况:
- 中心狭窄症 (MVS) 仍然是美国的重大公共卫生问题,患者人口统计数据不断变化.
- 导致MVS的风湿性心脏病在全球范围内持续存在,移民模式将其引入发达国家.
- 人口老龄化和心血管风险因素增加有助于退行性MVS和以前门干预的失败.
研究的目的:
- 审查当前的透导管治疗方案,以管理关狭窄症.
- 为提供对这种普遍的膜心脏病治疗策略的概述.
主要方法:
- 系统性文献综述对中枢狭窄症的透导管疗法.
- 对人口趋势和导致MVS患病率的病因因素的分析.
- 评估各种跨导管干预措施的有效性和安全性.
主要成果:
- 过导管疗法为MVS治疗提供了有希望的替代方案,特别是在高风险的手术候选人中.
- 新兴技术在治疗风湿性和退行性MVS方面显示出可行性和积极的结果.
- MVS治疗的景观正在转向更少的侵入性,透导管方法.
结论:
- 透导管干预是对关狭窄的日益增长和至关重要的治疗方式.
- 了解MVS不断变化的流行病学对于定制治疗策略至关重要.
- 通过导管治疗的持续研究和开发对于改善患者治疗结果至关重要.
相关概念视频
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...